| Literature DB >> 22675672 |
Melissa L Sokolosky1, Michael J Wargovich.
Abstract
The advent of modern medicine has allowed for significant advances within the fields of emergency care, surgery, and infectious disease control. Health threats that were historically responsible for immeasurable tolls on human life are now all but eradicated within certain populations, specifically those that enjoy higher degrees of socio-economic status and access to healthcare. However, modernization and its resulting lifestyle trends have ushered in a new era of chronic illness; one in which an unprecedented number of people are estimated to contract cancer and other inflammatory diseases. Here, we explore the idea that homeostasis has been redefined within just a few generations, and that diseases such as colorectal cancer are the result of fluctuating physiological and molecular imbalances. Phytochemical-deprived, pro-inflammatory diets combined with low-dose exposures to environmental toxins, including bisphenol-A (BPA) and other endocrine disruptors, are now linked to increasing incidences of cancer in westernized societies and developing countries. There is recent evidence that disease determinants are likely set in utero and further perpetuated into adulthood dependent upon the innate and environmentally acquired phenotype unique to each individual. In order to address a disease as multi-factorial, case-specific, and remarkably adaptive as cancer, research must focus on its root causes in order to elucidate the molecular mechanisms by which they can be prevented or counteracted via plant-derived compounds such as epigallocatechin-3-gallate (EGCG) and resveratrol. The significant role of epigenetics in the regulation of these complex processes is emphasized here to form a comprehensive view of the dynamic interactions that influence modern-day carcinogenesis, and how sensibly restoring homeostatic balance may be the key to the cancer riddle.Entities:
Keywords: cancer stem cell; chemoprevention; colon cancer; environmental toxin; epigenetic; inflammation; phytochemical; xenoestrogen
Year: 2012 PMID: 22675672 PMCID: PMC3365481 DOI: 10.3389/fonc.2012.00057
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244
Examples of exogenously obtained compounds, including common environmental toxins and phytochemicals, theorized to play a role in the acceleration or prevention of chronic disease by influencing homeostasis.
| Compounds: environmental toxins | Class | Common sources | Hormonal activity | Epigenetic activity | Bioaccum. in humans and env. | Inflamm. | Cancer | Other diseases/effects |
|---|---|---|---|---|---|---|---|---|
| Bisphenol-A (BPA) | Plastic monomer | Polycarbonate (#7) plastics, epoxy resins, dental sealants, food/bev packages, receipts | X +: ERα, SRCs | X, TG +: EZH2, DNMTs | X | ++ | + | +: ED, OB, CVD, DM, R, NB, I-A |
| +: EGFR, IGFR | ||||||||
| Phthalates (ex: DEHP) | Plasticizer | Personal care products, cleaning products, PVC (vinyl)-flooring, blood bags, toys | X | X | X | + | + | +: ED, OB, R, NB |
| +: ERα, SXR | +: MDR1 | |||||||
| −: AR | ||||||||
| Atrazine | Herbicide | Produce, groundwater and drinking water | X+: ARO | X | X | + | + | +: ED, OB, R |
| Triclosan | Pesticide | Antibacterial soap, water, toothpaste, acne products | X −: THs | X | X | + | +, M | +: ED, OB, R, I, AM-MR |
| DEET | Pesticide | Insect repellant, water | X +: ACh | X, TG | X | + | + | +: ED, OB, NB |
| PFCs (ex: PFOS, PFOA) | Surface coating | Non-stick pans, stain/H2O-resistant fabrics and food packaging surfaces | X +: PPARs | X +: DNMT3 | X POP | + | + +: ERK | +: ED, OB, CVD, R, I-Q |
| PBDEs (ex: Deca) | Flame retardant | Electronics, carpet, foam fillings, kids’ sleepwear, fish | X −: AR | X | X POP | + | + | +: ED, R |
| Dioxins (ex: TCDD) | Industrial byproduct | Meat/dairy, burning waste, engine exhaust, bleached products incl. sanitary items | X +: AhR | X, TG | X POP | + | ++: M | +: ED, OB, CVD, R, NB |
| Parabens (ex: methyl-) | Preservative | Personal care products, cosmetics, pharmaceuticals | X +: ERα | X | X | + | + | +: ED, OB, R, NB |
| Alkylphenols | Industrial intermed. | Detergents, lubricants, rubber resins, fragrances | X +: ERα | X | X | + | + | +: ED, OB, R |
| Formaldehyde | Industrial chemical | Glues, plywood, fiberboard home décor, nail polish | X | X | + | ++, M | ||
| Lead | Heavy metal | Soil, PVC (ex: toys, purses, pipes), paint (pre ban) | X | X | + | +, M | +: NB | |
| Omega-6s | Essential fatty acid | Animal fat, corn oil, processed food | X | X | ++ | + | +: OB, CVD, NB, I-A | |
| Omega-3s (DHA, EPA) | Essential fatty acid | Oily fish like wild-caught salmon, olive oil, flax seeds | X | X | – | − | −: OB, CVD, DM | |
| −: COX-2, NF-κB | ||||||||
| Epigallocatechin-3-gallate (EGCG) | Polyphenol flavonoid | Green tea (depleted in black tea due to oxidation; removed by decaffeination as well) | ? | X | In colon | – | –, −: EGFR | AOX, AA |
| −: DNMTs | −: COX-2, NF-κB | TOP, hTERT MMPs | −: OB, CVD, DM, NB, I-A | |||||
| Resveratrol | Polyphenol stilbene | Grape skin and seed | X | X | X | – | – | AOX, AM |
| +: ERβ > α | −: HAT | −: COX-2, NF-κB | −: PI3K | −: CVD, DM | ||||
| −: AhR | +: p21 | |||||||
| Genistein | Isoflavone | Soy beans, flax seed | X | X | X | − | − | AOX |
| +: ERβ > α | −: WNT5a | −: CVD, DM | ||||||
| Amygdalin | Glycoside | Apricot kernels, apple seeds, millet, alfalfa, strawberries | ? | ? | − | − | AOX, AM, oral tox.? | |
| −: COX-2, iNOS | −: Bcl-2, TOP | |||||||
| Azadirachtin | Limonoid | Neem tree | ? | ? | ? | − | −, −: Bcl-2 | AOX, AM |
| +: GST | +: R? | |||||||
| Quercetin | Flavonoid | Green and black tea, capers, onion, apples | X | X | X | − | − | AOX |
| +: ERβ > α | −: MRPs | |||||||
| Curcumin | Curcuminoid | Turmeric | ? | X | In colon | − | −, −:EGFR | AOX, AM |
| −: NF-κB | −: Bcl-XL | −: I-A, NB | ||||||
| +: p53, p38 |
+, promoting effect; −, attenuating effect; AA, anti-angiogenic; ACh, acetylcholine; AhR, aryl hydrocarbon receptor; AM, antimicrobial; AOX, antioxidant; AR, androgen receptor; ARO, aromatase; CVD, cardiovascular disease; DM, diabetes mellitus; ED, endocrine disruption; ER, estrogen receptor; I, immunological effects (A: autoimmune, Q: acquired); M, mutagen; MR, microbial resistance; NB, neurological/behavioral effects; OB, obesity; POP, persistent organic pollutant; R, reproductive effects; SRC, steroid receptor coactivator; SXR, steroid xenobiotic receptor;TG, transgenerational; THs, thyroid hormones; TOP, topoisomerase.
Figure 1Structural examples of phytochemicals with known or suspected medicinal properties such as antioxidant, antimicrobial, anti-inflammatory, and anti-cancer activity, likely stemming from protective and defensive roles in their plant sources.
Figure 2The dynamic epigenetic interplay of inflammation, environmental toxins, and phytochemicals theorized to lead to homeostatic imbalance and chronic disease in modernized societies; the manifestation and extent of which depends upon the hypothetical timing of critical gene expression changes in stem cells during embryogenesis, wound healing, and colon carcinogenesis (in this scenario), with other outcomes plausible.
Figure 3Structures of common xenoestrogens capable of influencing estrogenic signaling through agonistic and/or antagonistic mechanisms.